Cargando…
Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye
Intra-arterial chemotherapy (IAC) has assumed a major role in the management of retinoblastoma. This targeted therapy involves the delivery of chemotherapy directly into the ophthalmic artery, minimizing systemic absorption. We report a case of retinoblastoma regression in the untreated eye followin...
Autores principales: | Su, Grace L., Lim, Li-Anne S., Welch, R. Joel, Shields, Carol L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819715/ https://www.ncbi.nlm.nih.gov/pubmed/31686972 http://dx.doi.org/10.1016/j.sjopt.2019.05.007 |
Ejemplares similares
-
Parafoveolar retinoblastoma regression with foveal preservation following intra-arterial chemotherapy documented on hand-held optical coherence tomography in a newborn
por: Yarovaya, Vera, et al.
Publicado: (2017) -
Update on Intra-Arterial Chemotherapy for Retinoblastoma
por: Zanaty, Mario, et al.
Publicado: (2014) -
Intra-arterial chemotherapy in retinoblastoma – A paradigm change
por: Manjandavida, Fairooz P, et al.
Publicado: (2019) -
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras
por: Selzer, Evan B, et al.
Publicado: (2019) -
Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome
por: Dillon, Alexander B., et al.
Publicado: (2016)